The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins

<b>Objective.</b> To evaluate the incidence of post-embolization syndrome (PES) and the effect of venoactive therapy on its development, severity, and duration after endovascular embolization of gonadal veins (EEGV) with coils in patients with pelvic congestion syndrome (PCS). <b>M...

Full description

Bibliographic Details
Main Authors: Sergey Gennadievich Gavrilov, Gennady Vladimirovich Krasavin, Nadezhda Yurievna Mishakina, Oksana Igorevna Efremova, Igor Anatolievich Zolotukhin
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/6/521
_version_ 1797531191979540480
author Sergey Gennadievich Gavrilov
Gennady Vladimirovich Krasavin
Nadezhda Yurievna Mishakina
Oksana Igorevna Efremova
Igor Anatolievich Zolotukhin
author_facet Sergey Gennadievich Gavrilov
Gennady Vladimirovich Krasavin
Nadezhda Yurievna Mishakina
Oksana Igorevna Efremova
Igor Anatolievich Zolotukhin
author_sort Sergey Gennadievich Gavrilov
collection DOAJ
description <b>Objective.</b> To evaluate the incidence of post-embolization syndrome (PES) and the effect of venoactive therapy on its development, severity, and duration after endovascular embolization of gonadal veins (EEGV) with coils in patients with pelvic congestion syndrome (PCS). <b>Materials and Methods.</b> We analyzed the outcomes of EEGV with coils in 70 female patients who received (<i>n</i> = 38; group 1) or did not receive (<i>n</i> = 32; group 2) treatment with a venoactive drug (VAD) before and after the procedure. Assessments of the EEGV efficacy and for possible signs of PES were done on days 1, 5, 10, 15, 20, and 30 after the intervention. All patients underwent transvaginal and transabdominal duplex ultrasound scanning (DUS) after EEGV. In addition, patients with PES were examined using the computed tomography of the pelvic veins in the postprocedural period. <b>Results.</b> Technical success of EEGV was achieved in 100% of patients. Pelvic venous pain (PVP) reduction after EEGV was observed in 77.1% of patients. The PES was diagnosed in 18.6% of cases (10.5% in group 1 vs. 28.1% in group 2, <i>p</i> > 0.05). In three patients of group 1, the protrusion of coils was suspected and eventually verified during the resection of the left gonadal vein with coils. The group 1 patients had less severe post-embolization pain (6.2 ± 0.4 vs. 7.8 ± 0.3 scores in group 2; <i>p</i> = 0.009) and three times shorter duration of PES (5.0 ± 1.2 vs. 16.2 ± 2.7 days; <i>p</i> = 0.003). No significant differences in the diameters of gonadal veins, side of embolization, and number of coils were revealed between patients with and without PES. The rate of parametrium vein thrombosis was found to be significantly higher in patients with PES than in those without PES (30.7% vs. 18.5%, respectively; <i>p</i> < 0.05). <b>Conclusion.</b> The PES is a frequent complication of EEGV with coils and occurs in 18.6% of patients. Venoactive treatment does not effect the incidence of this complication but reduces the PES severity and duration.
first_indexed 2024-03-10T10:40:24Z
format Article
id doaj.art-d09b3cdfb6cc47f696210256b045b3a2
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-10T10:40:24Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-d09b3cdfb6cc47f696210256b045b3a22023-11-21T23:02:16ZengMDPI AGJournal of Personalized Medicine2075-44262021-06-0111652110.3390/jpm11060521The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal VeinsSergey Gennadievich Gavrilov0Gennady Vladimirovich Krasavin1Nadezhda Yurievna Mishakina2Oksana Igorevna Efremova3Igor Anatolievich Zolotukhin4Department of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, 119049 Moscow, RussiaDepartment of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, 119049 Moscow, RussiaDepartment of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, 119049 Moscow, RussiaDepartment of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, 119049 Moscow, RussiaDepartment of Fundamental and Applied Research in Surgery, Pirogov Russian National Research Medical University, 10/5 Leninsky Prospect, 119049 Moscow, Russia<b>Objective.</b> To evaluate the incidence of post-embolization syndrome (PES) and the effect of venoactive therapy on its development, severity, and duration after endovascular embolization of gonadal veins (EEGV) with coils in patients with pelvic congestion syndrome (PCS). <b>Materials and Methods.</b> We analyzed the outcomes of EEGV with coils in 70 female patients who received (<i>n</i> = 38; group 1) or did not receive (<i>n</i> = 32; group 2) treatment with a venoactive drug (VAD) before and after the procedure. Assessments of the EEGV efficacy and for possible signs of PES were done on days 1, 5, 10, 15, 20, and 30 after the intervention. All patients underwent transvaginal and transabdominal duplex ultrasound scanning (DUS) after EEGV. In addition, patients with PES were examined using the computed tomography of the pelvic veins in the postprocedural period. <b>Results.</b> Technical success of EEGV was achieved in 100% of patients. Pelvic venous pain (PVP) reduction after EEGV was observed in 77.1% of patients. The PES was diagnosed in 18.6% of cases (10.5% in group 1 vs. 28.1% in group 2, <i>p</i> > 0.05). In three patients of group 1, the protrusion of coils was suspected and eventually verified during the resection of the left gonadal vein with coils. The group 1 patients had less severe post-embolization pain (6.2 ± 0.4 vs. 7.8 ± 0.3 scores in group 2; <i>p</i> = 0.009) and three times shorter duration of PES (5.0 ± 1.2 vs. 16.2 ± 2.7 days; <i>p</i> = 0.003). No significant differences in the diameters of gonadal veins, side of embolization, and number of coils were revealed between patients with and without PES. The rate of parametrium vein thrombosis was found to be significantly higher in patients with PES than in those without PES (30.7% vs. 18.5%, respectively; <i>p</i> < 0.05). <b>Conclusion.</b> The PES is a frequent complication of EEGV with coils and occurs in 18.6% of patients. Venoactive treatment does not effect the incidence of this complication but reduces the PES severity and duration.https://www.mdpi.com/2075-4426/11/6/521pelvic congestion syndromeendovascular embolization of the gonadal veinspost-embolization syndromevenoactive drug
spellingShingle Sergey Gennadievich Gavrilov
Gennady Vladimirovich Krasavin
Nadezhda Yurievna Mishakina
Oksana Igorevna Efremova
Igor Anatolievich Zolotukhin
The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins
Journal of Personalized Medicine
pelvic congestion syndrome
endovascular embolization of the gonadal veins
post-embolization syndrome
venoactive drug
title The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins
title_full The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins
title_fullStr The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins
title_full_unstemmed The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins
title_short The Effect of Venoactive Drug Therapy on the Development and Severity of Post-Embolization Syndrome in Endovascular Interventions on the Gonadal Veins
title_sort effect of venoactive drug therapy on the development and severity of post embolization syndrome in endovascular interventions on the gonadal veins
topic pelvic congestion syndrome
endovascular embolization of the gonadal veins
post-embolization syndrome
venoactive drug
url https://www.mdpi.com/2075-4426/11/6/521
work_keys_str_mv AT sergeygennadievichgavrilov theeffectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT gennadyvladimirovichkrasavin theeffectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT nadezhdayurievnamishakina theeffectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT oksanaigorevnaefremova theeffectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT igoranatolievichzolotukhin theeffectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT sergeygennadievichgavrilov effectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT gennadyvladimirovichkrasavin effectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT nadezhdayurievnamishakina effectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT oksanaigorevnaefremova effectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins
AT igoranatolievichzolotukhin effectofvenoactivedrugtherapyonthedevelopmentandseverityofpostembolizationsyndromeinendovascularinterventionsonthegonadalveins